Both in Pharmaceuticals
Tvardi Therapeutics vs Palatin Technologies
Over the past year TVRD returned −79.7% and PTN returned −45.5%; their daily moves had a correlation of -0.01.
TVRD −79.7% PTN −45.5%Growth of $1, one year, split-adjusted
| Metric | TVRD | PTN |
|---|---|---|
| Price | $0.8614 | $6.02 |
| Market cap | $11.5M | $10.7M |
| Today | +3.17% | +15.33% |
| 1 month | −20.2% | −36.0% |
| 6 months | −76.5% | −68.3% |
| Year to date | −80.0% | −60.9% |
| 1 year | −80.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1449.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $15.8M | $7.5M |
| Dividend yield | — | — |
| Volatility (60d) | 88.7% | 112.9% |
| Short % of float | 6.9% | 19.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).